Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
European Radiology|April 9, 2015
Effect of TIPS placement on portal and splanchnic arterial blood flow in 4-dimensional flow MRIZoran Stankovic, Martin Rössle, Wulf Euringer, et al.Hepatology (Baltimore, Md.)|August 5, 2010
High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trialUlrich F H Leuschner, Birgit Lindenthal, Günter Herrmann, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 4, 2019
Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased SurvivalJonel Trebicka, Diana Bastgen, Jonathan Byrtus, et al.BMJ Open|April 15, 2025
Implementation of an electronic medication management support system in hospitalised polypharmacy patients: study protocol of a stepped-wedge cluster-randomised controlled trial (TOP study)Sarah Meyer, Sara Söling, David Lampe, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2014
The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-studyWolfgang Kreisel, Peter Deibert, Limas Kupcinskas, et al.Gastroenterology|May 20, 2015
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical TherapyTilman Sauerbruch, Martin Mengel, Matthias Dollinger, et al.Hepatology (Baltimore, Md.)|October 24, 2017
Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortalityChristian Jansen, Philipp Möller, Carsten Meyer, et al.Deutsches Arzteblatt International|February 20, 2024
Digital Medication Management in Polypharmacy—Findings of a Cluster-Randomized, Controlled Trial With a Stepped-Wedge Design in Primary Care Practices (AdAM)Robin Brünn, Jale Basten, Dorothea Lemke, et al.Plos One|June 10, 2015
Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical TrialBenjamin Heidrich, Hans-Jörg Cordes, Hartwig Klinker, et al.Journal of Hepatology|January 18, 2011
Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis CMichael Manns, Stefan Zeuzem, Ajit Sood, et al.Pageof 6